HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oblique metatarsal osteotomy for intractable plantar keratosis: 10-year follow-up.

Abstract
Twenty patients (14 women and 6 men) (23 feet) had a single oblique osteotomy operation of the 2nd, 3rd, or 4th metatarsal without fixation during an 8-year period. The mean age was 46 years (range, 21-64 years). Each patient had a painful intractable plantar keratosis preoperatively. The average follow-up was 10 years (range, 3-14 years). Postoperatively, reoperation was performed in four feet because of painful callosities. For 13 of the 19 feet that did not have reoperation, patients were limited in footwear or required a shoe insert. Overall results were good for 10 feet, fair for 7 feet, and poor for 6 feet. The only complication was a deep infection that occurred in one foot (good result). Nonunion occurred in one foot and delayed union in one. The average decrease in metatarsal length after osteotomy was 6+/-6 mm. The single oblique lesser metatarsal osteotomy may be successful, but one half of the patients continued to have some degree of pain and most patients had limitations in footwear. Overall results were disappointing, and patients who are offered this procedure should be advised of its limitations.
AuthorsO B Idusuyi, H B Kitaoka, G L Patzer
JournalFoot & ankle international (Foot Ankle Int) Vol. 19 Issue 6 Pg. 351-5 (Jun 1998) ISSN: 1071-1007 [Print] United States
PMID9677076 (Publication Type: Journal Article)
Topics
  • Adult
  • Callosities (surgery)
  • Female
  • Follow-Up Studies
  • Forefoot, Human (surgery)
  • Humans
  • Male
  • Metatarsal Bones (surgery)
  • Middle Aged
  • Osteotomy (methods)
  • Pain (etiology)
  • Reoperation
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: